A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1999
10/13/1999	EP0949331A1 Established microglia
10/13/1999	EP0949271A1 Novel dna, novel protein, and novel antibody
10/13/1999	EP0949270A1 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment
10/13/1999	EP0948651A1 Recombinant n-smases and nucleic acids encoding same
10/13/1999	EP0948637A1 Live recombinant avian vaccine, using the infectious laryngotracheitis avian virus as vector
10/13/1999	EP0948636A1 Transfecting composition usable in gene therapy combining a recombinant virus incorporating an exogenous nucleic acid, a non-viral and non-plasmid transfecting agent
10/13/1999	EP0948632A1 Methods for the characterization and selection of rna target motifs that bind compounds of pharmaceutical use
10/13/1999	EP0948627A2 Glutathionylspermidine synthetase
10/13/1999	EP0948625A2 USPA1 AND USPA2 ANTIGENS OF $i(MORAXELLA CATARRHALIS)
10/13/1999	EP0948624A2 Mutants of streptococcal toxin a and methods of use
10/13/1999	EP0948622A1 Human mage-like protein
10/13/1999	EP0948621A1 Junctional adhesion molecule (jam), a transmembrane protein of tight junctions
10/13/1999	EP0948620A2 Secreted proteins and polynucleotides encoding them
10/13/1999	EP0948619A1 Expression of proteins for treating asthma via ligand mediated activation of their encoding genes
10/13/1999	EP0948618A1 HUMAN POLYHOMEOTIC 2($i(hph2)) ACTS AS AN ONCOGENE
10/13/1999	EP0948617A1 A NOVEL CLONED GABA-RECEPTOR SUBUNIT cDNA SEQUENCE AND STABLY CO-TRANSFECTED CELL LINES
10/13/1999	EP0948611A1 Ve-cadherin promoter and its uses
10/13/1999	EP0948609A2 Llg polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies
10/13/1999	EP0948605A1 Truncated platelet-activating factor acetylhydrolase
10/13/1999	EP0948597A1 HUMAN MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MAdCAM-1) AND SPLICE VARIANTS THEREOF
10/13/1999	EP0948545A1 Antibodies specifically recognising a nitrosylated protein, method of preparation, therapeutic and diagnostic use
10/13/1999	EP0948542A1 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
10/13/1999	EP0948541A2 Analogs of parathyroid hormone
10/13/1999	EP0948539A2 Peptides and compounds that bind to a receptor
10/13/1999	EP0948538A1 Analysis and separation of platelet-derived growth factor proteins
10/13/1999	EP0948536A1 A g protein-coupled receptor with an enlarged extracellular domain
10/13/1999	EP0948535A1 Novel lanthionine antibiotic compositions and methods
10/13/1999	EP0948534A1 Meningococcus vaccine comprising the valence of bz83 strain
10/13/1999	EP0948527A1 Cyclosporin derivatives, their preparation and pharmaceutical compositions containing them
10/13/1999	EP0948526A1 Contryphan peptides
10/13/1999	EP0948525A1 Cyclic peptide derivatives
10/13/1999	EP0948524A1 Peptides agonists of bradykinine b 2? receptor
10/13/1999	EP0948523A1 Peptidomimetic inhibitors of the human cytomegalovirus protease
10/13/1999	EP0948522A1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
10/13/1999	EP0948518A1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
10/13/1999	EP0948515A1 Human b-cell translocation genes-2 and 3
10/13/1999	EP0948513A1 Delivery construct for antisense nucleic acids and methods of use
10/13/1999	EP0948508A1 Novel coding sequences from herpes simplex virus type-2
10/13/1999	EP0948358A1 Stable liquid interferon formulations
10/13/1999	EP0948356A1 Agent for identifying and treating metastasizing tumours
10/13/1999	EP0948355A1 Treatment of lupus nephritis with anti-cd40l compounds
10/13/1999	EP0948354A1 Calcium-independent modulation by cd81 of receptor signalling
10/13/1999	EP0948353A1 Methods and compositions for immunomodulation
10/13/1999	EP0948349A1 Treatment of inner ear hair cells
10/13/1999	EP0948348A1 Manipulation of non-terminally differentiated cells using the notch pathway
10/13/1999	EP0948347A1 Antiviral and antitumor agents
10/13/1999	EP0948346A1 USE OF CONOTOXIN PEPTIDES ImI AND MII AS CARDIOVASCULAR AGENTS
10/13/1999	EP0948345A1 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction
10/13/1999	EP0948344A1 Synthetic antibiotics
10/13/1999	EP0948343A1 Alkyl peptide amides and applications
10/13/1999	EP0948342A1 MEDICAL USES OF scuPA/suPAR COMPLEX
10/13/1999	EP0948341A1 Phospholipid drug derivatives
10/13/1999	EP0948337A1 Treatment of hemoglobin containing erythrocytes with nitric oxide
10/13/1999	EP0948334A1 Method of treating prostatic diseases using active vitamin d analogues
10/13/1999	EP0948323A1 Protease-activated receptor 3 and uses thereof
10/13/1999	EP0948317A1 Dispersible macromolecule compositions and methods for their preparation and use
10/13/1999	EP0948308A1 Methods for treating skin pigmentation
10/13/1999	EP0948258A1 Brain targeted low molecular weight hydrophobic antioxidant compounds
10/13/1999	EP0948255A1 Improved chondrogenic differentiation of human mesenchymal stem cells
10/13/1999	EP0828503A4 Treatment for inhibiting the progression of autoimmune disease
10/13/1999	EP0793502A4 Novel hedgehog-derived polypeptides
10/13/1999	EP0770088A4 Novel cytokine designated lerk-5
10/13/1999	EP0672192B1 Method for inhibition of viral morphogenesis
10/13/1999	EP0658111B1 Methods for enhancing drug delivery with modified saponins
10/13/1999	EP0618968B1 Tools for the diagnosis and treatment of alzheimer's disease
10/13/1999	EP0564592B1 Liver enriched transcription factor
10/13/1999	CN1231696A Homocysteine desulphurase from the protozoan trichomonas vaginalis
10/13/1999	CN1231694A Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase
10/13/1999	CN1231676A Parathyroid hormone analogues for the treatment of osteoporosis
10/13/1999	CN1231675A Modified physiologically active proteins and medicinal compositions containing the same
10/13/1999	CN1231674A Use of proteins as anti-retroviral agents
10/13/1999	CN1231672A Conformationally constrained backbone cyclized somatostatin analogs
10/13/1999	CN1231671A Antithrombotic azacycloalkylakanoyl peptides and pseudopeptides
10/13/1999	CN1231659A Stable non-hygroscopic crystalline form of N-[N-N-(4-(piperidin-4-YL) butanoyl)-N-ethylglycyl] compound
10/13/1999	CN1231612A Inhibition of 2,3-dihydrogen-indone to 26S and 20S prolease
10/13/1999	CN1231601A Oral delayed immediate release formulation and method of preparation therefor
10/13/1999	CN1231183A Method for preparing medicine for growing leukocyte by Chinese silkworm production gene engineering
10/13/1999	CN1045594C Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system
10/13/1999	CN1045539C CDNA clones coding for polypeptides exhibiting human granulocyte macrophage and eosinophie cellular growth
10/12/1999	US5965789 Engineering protein posttranslational modification by PACE/furin in transgenic non-human mammals
10/12/1999	US5965787 HLA-DRBI peptides with specific binding affinity for HLA-DQ molecules: prevention and treatment of rheumatoid arthritis
10/12/1999	US5965725 Polypeptides, and preparation and DNA encoding thereof
10/12/1999	US5965724 GP 130 lacking the transmembrane domain
10/12/1999	US5965723 DNA encoding epithelins
10/12/1999	US5965714 Method for the covalent attachment of polysaccharides to protein molecules
10/12/1999	US5965712 A trimeric protein with an isoleucine zipper configuration and an extracellular domanin of cd23; interacts strongly with immunoglobulin e; antihistamines, antiallergens
10/12/1999	US5965711 A protein; anticarcinogenic/antiarthritic/antidiabetic agents; treatment of addison's and crohn's disease, multiple sclerosis, scleroderma, ulcers, respiratory disorders; fungicides, viricides, bactericides
10/12/1999	US5965710 An immunoglobulin which binds human membrane-bound carcinoembryonic antigen; anticarcinogenic agent
10/12/1999	US5965706 Anticarcinogenic agents; treatment and diagnosis of addison's disease, respiratory infections, crohn's disease, diabetes, multiple sclerosis, rheumatic diseases, anemia, antihistamines, antiallergens
10/12/1999	US5965703 Bcl-x/bcl-2 associated death polypeptide; used for regulating apoptosis in treating acquired immune deficiency syndrome and neurodegenerative diseases; antiischemic agents
10/12/1999	US5965701 Kappa receptor opioid peptides
10/12/1999	US5965698 Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
10/12/1999	US5965697 Disaggregated mutant human RANTES
10/12/1999	US5965696 Potassium channel modulators
10/12/1999	US5965695 Modified peptide and peptide libraries with protease resistance, derivatives thereof and methods of producing and screening such
10/12/1999	US5965694 Cyclic peptides which bind to g protein linked receptors and are more stable in human body
10/12/1999	US5965693 Isolated polynucleotides; diagnosis and treatment of autoimmune diseases, tissue rejection, allergies, acquired immune deficiency disorder, viricides, bactericides, fungicides and anticarcinogenic agents
10/12/1999	US5965692 Anticoagulants for treatment of thromobosis and hypercoagulability in blood and tissues
10/12/1999	US5965601 Novel compounds for inhibiting replication of a retrovirus; treating hiv
10/12/1999	US5965596 Providing an amount of beta-alanine to blood to increase beta-alanylhistidine dipeptide synthesis in the human tissue, simultaneous accumulation of creatine within a tissue

1 ... 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 ... 3163